menu search

Seeing machines' top line growth beats market forecasts

Seeing Machines Ltd (AIM:SEE, OTC:SEEMF) said revenues for the year increased by a better-than-expected 48% to US$57.8 million as its eye-tracking te...

October 16, 2023, 3:01 am

Buy yang to profit from china's bursting bubble

Chinese stocks are expected to decline significantly due to geopolitical tensions with the USA, a bursting real estate bubble, and global recession ri...

October 16, 2023, 2:58 am

Pfizer's sequel: return of the value stock

Pfizer is focusing on its core growth engines and strategic acquisitions, particularly in the oncology segment, to compensate for downgraded revenue p...

October 16, 2023, 2:53 am

Guild esports player chico wins 3rd place in fortnite champion series

Professional Fortnite player 'Chico' has won $200,000 after finishing third in the prestigious Fortnite Champion Series final while playing under the ...

October 16, 2023, 2:32 am

Denbury: a deep dive into financial metrics, liquidity concerns, and investment potential

Denbury Inc.'s balance sheet shows growth in total assets and stockholders' equity, but also a significant ...

October 16, 2023, 2:31 am

Pboc sets usd/ cny reference rate for today at 7.1798 (vs. estimate at 7.3121)

The People's Bank of China set the onshore yuan (CNY) reference rate for the trading session ahead.USD/CNY is the onshore yuan. Its permitted to trade...

October 16, 2023, 1:15 am

Scalper signal mt4 indicator

In the ever-evolving world of forex trading, having the right tools at your disposal can make all the difference between success and failure. One such...

October 16, 2023, 12:00 am

Netflix: headwinds, just how big?

Netflix's share price has been under pressure due to lagging expectations in cracking down on password sharing and generating advertising revenues. Th...

October 15, 2023, 11:54 pm

Enghouse systems: the transition to saas is promising

Enghouse Systems is a Canadian software and services company that specializes in customer engagement solutions and telecommunications software. EGHSF ...

October 15, 2023, 11:39 pm

Super micro computer: price consolidation amid strong fundamentals

Super Micro Computer, Inc. reported impressive Q4 2023 financial results with a significant increase in...

October 15, 2023, 9:24 pm

Activist builds news corp stake, plans to seek changes

Starboard believes the media company trades at a significant discount due to its structure....

October 15, 2023, 7:00 pm

Transforming the crypto landscape with bitcoin, ethereum, and bitcoin spark’s unmatched vision

Bitcoin and Ethereum birthed the digital currency ecosphere. These two digital assets play a significant ...

October 15, 2023, 1:59 pm

Should you buy bitcoin while it’s below $30,000?

Looking out even 12 months from now, it’s possible that Bitcoin’s price will be significantly higher than today, which means buying it for less th...

October 15, 2023, 10:29 am

A bull market could be here: 3 reasons to buy coca-cola stock

Its ability to innovate and adapt is a significant driver behind its consistent revenue growth. Its upw...

October 15, 2023, 8:15 am

Exxon mobil: is it a good dividend stock?

Exxon Mobil has been a reliable dividend player but that doesn't mean ex-ante the dividend was never at risk. The company's scale and integrated model...

October 15, 2023, 6:25 am

Assertio holdings: uncovering a tapestry of trading opportunities from this oversold ticker

Assertio Holdings has undergone a significant transformation in its business model, reducing debt and e...

October 15, 2023, 4:41 am

Ethereum’s prolonged battle with bitcoin: who’s winning?

The gripping saga between Ethereum and Bitcoin has seen its highs and lows, twists and turns. And as the plot thickens in 2023, Ethereum’s native to...

October 15, 2023, 2:14 am

Rising us bond yields drive fpis to sell indian equities

In a significant financial shift, foreign portfolio investors (FPIs) continue their selling streak in I...

October 15, 2023, 12:59 am

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm

Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (

Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...

October 14, 2023, 8:30 pm


Search within

Pages Search Results: